Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy. (27th February 2013)

• Record Type: Journal Article
• Authors: Porcello Marrone, Luiz Carlos; Marrone, Bianca Fontana; Pascoal, Tharick Ali; Schilling, Lucas Porcello; Soder, Ricardo Bernardi; Ferreira, Sheila Schuch; Gadonski, Giovani; da Costa, Jaderson Costa
• Other Names: Aogi K. Academic Editor.; Gennatas C. Academic Editor.; Reyes C. V. Academic Editor.; Ribera J. M. Academic Editor.
• Is Part Of: Case reports in oncological medicine. Volume 2013(2013)
• Publication Date: 2013-02-27
• Subjects: Oncology -- Periodicals; Tumors -- Periodicals; Oncology -- Case studies -- Periodicals; Neoplasms; Oncology; Tumors; Electronic journals; Periodicals; Case studies; Periodicals; Case Reports; Fulltext; Internet Resources; Periodicals; 616.994
• DOI: 10.1155/2013/306983
• Languages: English
• ISSNs: 2090-6706

Abstract

Abstract : Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.